TCL Archive FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart December 3, 2010
TCL Archive New Firm Steps Onto Texas Battleground for Control Over Office-Based Oncology November 22, 1996
TCL Archive In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs November 27, 1998
TCL Archive Preliminary estimates based on NLST results: Year Of Life Saved Could Cost $38,000 July 1, 2011
TCL Archive DCT Board Approves Continuing Neutron Trials Pas 1989 Expiration, With New Funding Plan June 10, 1988
